ISAL 2019 | Histamine dihydrochloride and IL-2 for AML: impacts for relapse risk and survival

Anna Martner

Anna Martner, PhD, of the University of Gothenburg, Gothenburg, Sweden, discusses the mechanism of action of the combination of histamine dihydrochloride and IL-2, and its impacts for relapse risk and survival in acute myeloid leukemia (AML). This interview was held at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Share this video